Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(38 sites)
United States
Emory University, Atlanta, Georgia Riley Hospital for Children, Indianapolis, Indiana Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio University of Utah, Salt Lake City, Utah Australia
Mater Hospital Brisbane Inflammatory Bowel Diseases, South Brisbane China
Capital Center For Children's health Capital Medical University, Beijing Changzhou No 2 Peoples Hospital, Changzhou The Childrens Hospital Zhejiang University School Of Medicine, Hangzhou Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou Ruijin Hospital Shanghai Jiao Tong University, Shanghai Shengjing Hospital Of China Medical University, Shenyang France
Hospital Center University De Lille, Lille Germany
Schon Klinik Hamburg Eilbek, Hamburg Asklepios Klinik Sankt Augustin, Sankt Augustin Italy
ASST Papa Giovanni XXIII Bergamo, Bergamo Azienda USL di Bologna - Ospedale Maggiore, Bologna IRCCS Ospedale Pediatrico Bambino Gesu, Roma IRCCS Materno Infantile Burlo Garofolo, Trieste Japan
Tokyo Metropolitan Children's Medical Center, Fuchū Kanazawa University Hospital, Kanazawa Kobe University Hospital, Kobe Japanese Red Cross Kumamoto Hospital, Kumamoto Shinshu University Hospital, Matsumoto Saga University Hospital, Saga Yokohama City University Medical Center, Yokohama Poland
Centrum Zdrowia Dziecka i Rodziny im Jana Pawla II w Sosnowcu Sp z o o, Sosnowiec Instytut Pomnik Centrum Zdrowia Dziecka, Warsaw Portugal
Uls Braga - Hosp. Braga, Braga South Korea
Severance Hospital Yonsei University Health System, Seoul Samsung Medical Center, Seoul Spain
Hosp. Clinico Univ. de Santiago, Santiago de Compostela Hosp. Univ. I Politecni La Fe, Valencia Turkey (Türkiye)
Gazi University Medical Faculty, Ankara Umraniye Training and Research Hospital, Istanbul Kocaeli Universitesi Hastanesi, Kocaeli United Kingdom
Royal Stoke University Hospital, Stoke-on-Trent